LI Wen-qian, HAN Jing-jing, ZHANG Xian, XU Run-ze, YANG Jin*. Assessment strategies for drug permeability during drug discovery and developmentJ. Acta Pharmaceutica Sinica, 2021,56(5): 1279-1285. doi: 10.16438/j.0513-4870.2021-0102
Citation: LI Wen-qian, HAN Jing-jing, ZHANG Xian, XU Run-ze, YANG Jin*. Assessment strategies for drug permeability during drug discovery and developmentJ. Acta Pharmaceutica Sinica, 2021,56(5): 1279-1285. doi: 10.16438/j.0513-4870.2021-0102

Assessment strategies for drug permeability during drug discovery and development

  • Permeability is a key factor in the bioavailability of oral drugs. Therefore, in the early stage of drug discovery, accurate and efficient evaluation of drug permeability is essential. The parallel artificial membrane permeability assay (PAMPA) with Caco-2 cells model was used by the industry as early evaluation methods. At present, the Ussing chamber rat model is also widely used. This review summarizes the human data for the in vivo single-pass perfusion technique (Loc-I-Gut)-the gold standard, and then focuses on the basic principles, experimental operation, and efficiency of the three in vitro methods, with correlation to the effective permeability coefficient (Peff) and fractional absorbed (Fa) in man. We provide recommendations for the use of proper permeability methods at different stages in drug discovery and development.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return